A committee of subject matter experts established by the Comptroller General of Drugs of India (DCGI) to review COVID-19 vaccine proposals, recommended an “interim efficacy analysis for Covaxin.” The vaccine was developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR). The expert committee asked a …
Read More »
NEW DELHI: The drug regulator’s Subject Matter Experts Committee (SEC) recommended on Friday the granting of an Emergency Use Authorization (USA) for the Serum Institute of India’s ‘Covishield’, raising hopes that it will soon be Covid vaccine available in India. The sources said that the SEC has recommended the EUA …
Read More »
India’s drug regulator will approve a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use on Friday, three sources with knowledge of the matter said. The decision would pave the way for the launch of the vaccine in the second most populous country in the world, which, after …
Read More »
The third ongoing vaccine, Bharat Biotech’s Covaxin, which is being developed in collaboration with the Indian Council for Medical Research (ICMR), is simultaneously undergoing Phase 3 human trials at 22 sites in India with around 26,000 volunteers. . According to a senior company official, it will be at least 60 …
Read More »
It’s December 31, the end of the year, and India may be just a day away from approving a vaccine. The Subject Matter Experts Committee (SEC) of the Central Medicines Standard Control Organization (CDSCO) on Wednesday reviewed data submitted by the Serum Institute of India and Bharat Biotech as requested …
Read More »
Amid concerns about the spread of the new coronavirus (Covid-19) strain in India, AIIMS Delhi Director Dr. Randeep Guleria said that the approval of the Oxford-AstraZeneca vaccine for use in the The UK was a “big step forward” and India was days away from achieving it. a vaccine. “It is …
Read More »
India is in a good position to mitigate the crisis Speaking on an optimistic note, Guleria said that although the new strain is more infectious, India can take steps to mitigate it because the government has established a consortium to monitor the spread of the virus. He said: “India is …
Read More »
Prime Minister Narendra Modi laid the foundation stone for the Indian Institute of Medical Sciences (AIIMS) in Rajkot in Gujarat on Thursday, where he said people should show caution and strictly adhere to preventive coronavirus standards even after they are administered. vaccines. “I used to say ‘jab tak davai nahi …
Read More »
AstraZeneca Plc will soon publish data showing that the effectiveness of its covid-19 vaccine increases up to 95% if the two injections are separated by approximately 2-3 months, said Adar Poonawalla, executive director of the Serum Institute of India (SII), partner. manufacturing company British. “You will be getting good news …
Read More »
The Serum Institute of India, which is manufacturing and testing the Oxford / AstraZeneca coronavirus vaccine in the country, said Monday. awaited regulatory approval to take in a few days. Serum CEO Adar Poonawalla said the vaccine, called Covishield in India, should be licensed by January. “The emergency use authorization …
Read More »